Best Pharmaceutical Stocks To Watch Today - March 13th

Key Points

• MarketBeat's screener flagged Eli Lilly, Pfizer, and Abbott Laboratories as the pharmaceutical stocks to watch based on the highest dollar trading volume in recent days; pharmaceutical shares are driven by R&D, clinical and regulatory outcomes, patent expirations, and pricing/reimbursement policies, making them potentially high-reward but volatile.
• Eli Lilly is highlighted for its diabetes and obesity portfolio—notably GLP-1 and related drugs such as Mounjaro, Trulicity, and Zepbound—amid intensifying GLP-1 competition.
• Pfizer is notable for vaccines and COVID-era treatments including Comirnaty, Paxlovid, and the Prevnar family, while Abbott provides diversified exposure across established pharmaceuticals, diagnostics, nutritional products, and medical devices.

Eli Lilly and Company, Pfizer, and Abbott Laboratories are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is developing, manufacturing, and selling prescription drugs, vaccines, and related therapies or services. For investors, these stocks are driven by factors such as R&D pipelines, clinical-trial and regulatory outcomes, patent expirations, and pricing/reimbursement policies, making them potentially high-reward but also subject to significant regulatory, clinical, and patent-related volatility. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Read Our Latest Research Report on PFE

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Read Our Latest Research Report on ABT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.